UNITEDHEALTH GROUP INC — Form 8-K
Filed October 13, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 42/100
What the filing says
UnitedHealth reported Q3 2026 revenues of $112.7B (down 0.4% YoY) and operating earnings of $6.6B (up 52% YoY). Diluted EPS was $4.56; adjusted EPS $4.69. The company raised full-year 2026 adjusted earnings guidance to at least $20.50 per share from prior levels, reflecting medical cost ratio improvement to 88.4% (vs. 89.9% YoY). However, UnitedHealthcare membership contracted by 1.185M since year-end 2025 (935K Medicare Advantage, 165K commercial, 85K Medicaid), partly offset by Optum's 120M+ patients served. The firm committed $1B to United Health Foundation and pledged 100% pass-through of drug rebates by Jan 1, 2028.
Why this rating
Guidance raise and margin improvement are positive; membership loss (~2.4% of 48.3M base) is concerning. Combined impact moderate relative to $281.9B market cap—typical quarterly performance, not trajectory-changing.
See more from October 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.